Client’s Testimonial:
“Thank you for the great news. Overall, very happy with the case preparation, valuable guidance, and timely responses.”
On January 30th, 2024, we received another EB-2 NIW (National Interest Waiver) approval for a Senior QA Specialist in the field of Pharmaceutical Sciences (Approval Notice).
General Field: Pharmaceutical Sciences
Position at the Time of Case Filing: Senior QA Specialist
Country of Origin: India
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: January 30th, 2024
Processing Time: 5 days (Premium Processing Requested)
Case Summary:
With an emphasis on a complete understanding of the outcome and its crucial quality attributes, a senior quality assurance specialist approached the North America Immigration Law Group with a proposal to further his research on using a quality-by-design approach to methodically design and develop investigational or shortened new drugs. Since his study is important for improving drug development and healthcare, we prepared a customized petition packet for his I-140 NIW petition, utilizing our extensive knowledge in the industry, which has helped over 32,000 individuals achieve favorable results.
We highlighted that his research has resulted in 10 peer-reviewed journal articles (3 of them first-authored), 2 granted patents, and 3 patent applications. Moreover, these papers have been published in authoritative publication venues in his field, including the highly ranked peer-reviewed journals. Also, his research has been published and influenced by his peers, with 15 citations on Google Scholar, demonstrating his widespread recognition and reliance in the pharmaceutical sciences field. His publications have been widely cited.
Besides, we discussed how to address some of the clinical, ethical, and financial challenges, adopting a quality-by-design approach is crucial. Our client’s success in this domain makes his work significant for the U.S. Leveraging his extensive experience equips the U.S. to enhance its drug discovery processes, making life-saving medicines safer, more ethical, accessible, and affordable. This not only establishes a world-class healthcare system for the country, it ensures that Americans receive quality care and treatment.
Furthermore, our client’s approach has applications in biotechnologies and artificial intelligence, which are identified as critical and emerging technology areas by the National Science and Technology Council. Their research achievements align with the US’s current goals and highlight the need for his continued research.
We are pleased to announce that our client’s National Interest Waiver (NIW) application petition was approved by USCIS within just five days. This was made possible by opting for the Premium Processing upgrade, a paid service offered by USCIS that enables faster adjudication of the petition. Our client had complete faith in the process, and we are grateful that he chose our law firm to present his NIW petition. The application was approved without any Request for Evidence (RFE), which is a testament to the quality of the application. We wish our client the very best for his future endeavors.
